Through translational prospective study, the GSTP1 Ile105Val polymorphism emerges as prognostic marker in de novo large B-cell lymphoma patients

od Delamain, M T, Miranda, E C M, Lourenço, G J, de Souza, C A, Lima, C S P
izdano v Blood Cancer J (2017)

NOVAS MEDIDAS DE ASSISTÊNCIA A PACIENTES COM DOENÇAS FALCIFORMES DURANTE A PANDEMIA DE COVID-19: EXPERIÊNCIA DE UM CENTRO BRASILEIRO

od Benites, B.D., Lino, J.C.A., Medina, S.S., Gilli, S.C.O., Delamain, M.T., Paula, E.V., Costa, F.F., Saad, S.T.O.
izdano v Hematol Transfus Cell Ther (2020)

VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens

od Lopes-Aguiar, L, Delamain, M T, Brito, A B C, Lourenço, G J, Costa, E F D, Oliveira, G B, Vassallo, J, De Souza, C A, Lima, C S P
izdano v Blood Cancer J (2017)

Association of VEGFA-2578 C>A polymorphism with clinicopathological aspects and outcome in follicular lymphoma patients

od de Mendonça, G R A, Brito, A B C, Rocha, R M, Delamain, M T, de Andrade Natal, R, Soares, F A, Colleoni, G W B, Souza, C A, Vassallo, J, Lima, C S P
izdano v Blood Cancer J (2016)

COVID-19 IN CHRONIC MYELOID LEUKEMIA PATIENTS – BRAZILIAN EXPERIENCE

od Pagnano, K.B.B., Toreli, A.C., Perobelli, L.M., Quixada, A.T., Seguro, F.S., Bendit, I., Delamain, M.T., Sapelli, J., Moura, M.S., Bortolini, J., Lourenço, A.L., Gonçalves, N.N., Conchon, M., Nucci, F.M., Oliveira, L.C., Magalhães, G.H., Funke, V., Tavares, R., Centrone, R.T., Santos, F.P., Fogliatto, L., Palma, L.C., Clementino, N.D., Hokama, P.O., Boquimpani, C.M.
izdano v Hematol Transfus Cell Ther (2020)